{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T05:00:12Z","timestamp":1790744412179,"version":"4.1.0"},"reference-count":108,"publisher":"MDPI AG","issue":"20","license":[{"start":{"date-parts":[[2021,10,17]],"date-time":"2021-10-17T00:00:00Z","timestamp":1634428800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Patients with diabetic kidney disease (DKD) are at very high risk for cardiovascular events. Only part of this increased risk can be attributed to the presence of diabetes mellitus (DM) and to other DM-related comorbidities, including hypertension and obesity. The identification of novel risk factors that underpin the association between DKD and cardiovascular disease (CVD) is essential for risk stratification, for individualization of treatment and for identification of novel treatment targets.In the present review, we summarize the current knowledge regarding the role of emerging cardiovascular risk markers in patients with DKD. Among these biomarkers, fibroblast growth factor-23 and copeptin were studied more extensively and consistently predicted cardiovascular events in this population. Therefore, it might be useful to incorporate them in risk stratification strategies in patients with DKD to identify those who would possibly benefit from more aggressive management of cardiovascular risk factors.<\/jats:p>","DOI":"10.3390\/ijms222011196","type":"journal-article","created":{"date-parts":[[2021,10,17]],"date-time":"2021-10-17T23:05:47Z","timestamp":1634511947000},"page":"11196","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Novel Cardiovascular Risk Factors in Patients with Diabetic Kidney Disease"],"prefix":"10.3390","volume":"22","author":[{"given":"Christodoula","family":"Kourtidou","sequence":"first","affiliation":[{"name":"First Propedeutic Department of Internal Medicine, Medical School, Aristotle University of Thessaloniki, AHEPA Hospital, 54636 Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2496-9863","authenticated-orcid":false,"given":"Maria","family":"Stangou","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Medical School, Aristotle University of Thessaloniki, Hippokration Hospital, 54642 Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Smaragdi","family":"Marinaki","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Renal Transplantation, Medical School, National and Kapodistrian University of Athens, Laiko Hospital, 11527 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3172-1594","authenticated-orcid":false,"given":"Konstantinos","family":"Tziomalos","sequence":"additional","affiliation":[{"name":"First Propedeutic Department of Internal Medicine, Medical School, Aristotle University of Thessaloniki, AHEPA Hospital, 54636 Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,10,17]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1053\/j.ackd.2017.10.011","article-title":"The Global Epidemiology of Diabetes and Kidney Disease","volume":"25","author":"Koye","year":"2018","journal-title":"Adv. Chronic Kidney Dis."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.kint.2017.01.030","article-title":"Diabetes with early kidney involvement may shorten life expectancy by 16 years","volume":"92","author":"Wen","year":"2017","journal-title":"Kidney Int."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/S0140-6736(12)60572-8","article-title":"Alberta Kidney Disease Network. Risk of coronary events in people with chronic kidney disease compared with those with diabetes: A population-level cohort study","volume":"380","author":"Tonelli","year":"2012","journal-title":"Lancet"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.2215\/CJN.00980110","article-title":"The origin of multiple molecular forms in urine of HNL\/NGAL","volume":"5","author":"Cai","year":"2010","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.2147\/DMSO.S258678","article-title":"Evaluation of Urinary Neutrophil Gelatinase Associated Lipocalin and Kidney Injury Molecule-1 as Diagnostic Markers for Early Nephropathy in Patients with Type 2 Diabetes Mellitus","volume":"13","author":"Quang","year":"2020","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"419","DOI":"10.7754\/Clin.Lab.2019.190326","article-title":"Urinary Neutrophil Gelatinase-Associated Lipocalin (NGAL) as a Marker of Diabetic Nephropathy in Type 1 Diabetic Patients","volume":"66","author":"Sisman","year":"2020","journal-title":"Clin. Lab."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1159\/000505155","article-title":"Neutrophil Gelatinase-Associated Lipocalin and Retinol-Binding Protein-4 as Biomarkers for Diabetic Kidney Disease","volume":"45","author":"Abbasi","year":"2020","journal-title":"Kidney Blood Press. Res."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"5103","DOI":"10.2147\/DMSO.S282166","article-title":"Potential Role and Excretion Level of Urinary Transferrin, KIM-1, RBP, MCP-1 and NGAL Markers in Diabetic Nephropathy","volume":"13","author":"Siddiqui","year":"2020","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.clinbiochem.2015.10.016","article-title":"Urinary kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin as indicators of tubular damage in normoalbuminuric patients with type 2 diabetes","volume":"49","author":"Tatsch","year":"2016","journal-title":"Clin. Biochem."},{"key":"ref_10","first-page":"270","article-title":"Assessment of Serum and Urine Neurophil Gelatinase-Associated Lipocalin (s-NGAL and u-NGAL) Level as a Predictive Factor of Disease Progression in Diabetic Nephropathy in Type 2 DM","volume":"15","author":"Najafi","year":"2021","journal-title":"Iran J. Kidney Dis."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Lee, J.H., Yang, F.J., Tsai, W.Y., Lee, C.T., Liu, S.Y., Yang, W.S., and Tung, Y.C. (2021). Serum neutrophil gelatinase-associated lipocalin as a potential biomarker of diabetic kidney disease in patients with childhood-onset type 1 diabetes. J. Formos. Med. Assoc., Epub ahead of print.","DOI":"10.1016\/j.jfma.2021.06.022"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1111\/nep.13851","article-title":"Significant association of urinary alpha-1-microglobulin compared to urinary neutrophil gelatinase-associated lipocalin with renal insufficiency in patients with type 2 diabetes","volume":"26","author":"Chen","year":"2021","journal-title":"Nephrol. Carlton."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.jdiacomp.2019.05.013","article-title":"Urinary biomarkers of tubular injury to predict renal progression and end stage renal disease in type 2 diabetes mellitus with advanced nephropathy: A prospective cohort study","volume":"33","author":"Satirapoj","year":"2019","journal-title":"J. Diabetes Complicat."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/j.ekir.2021.01.012","article-title":"Evaluation of Urinary Biomarkers of Proximal Tubular Injury, Inflammation, and Fibrosis in Patients with Albuminuric and Nonalbuminuric Diabetic Kidney Disease","volume":"6","author":"Phanish","year":"2021","journal-title":"Kidney Int. Rep."},{"key":"ref_15","first-page":"7659243","article-title":"Markers of Glomerular and Tubular Damage in the Early Stage of Kidney Disease in Type 2 Diabetic Patients","volume":"2018","author":"Dumnicka","year":"2018","journal-title":"Mediat. Inflamm."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.3892\/etm.2013.1315","article-title":"Urinary TNF-\u03b1 and NGAL are correlated with the progression of nephropathy in patients with type 2 diabetes","volume":"6","author":"Wu","year":"2013","journal-title":"Exp. Ther. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1080\/03009734.2016.1192704","article-title":"Associations between urinary kidney injury biomarkers and cardiovascular mortality risk in elderly men with diabetes","volume":"121","author":"Tonkonogi","year":"2016","journal-title":"Upsala J. Med. Sci."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1007\/s00592-018-1205-0","article-title":"Urinary tubular biomarkers as predictors of kidney function decline, cardiovascular events and mortality in microalbuminuric type 2 diabetic patients","volume":"55","author":"Rotbain","year":"2018","journal-title":"Acta Diabetol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.amjcard.2018.10.035","article-title":"EXAMINE Investigators. Relation of Serum and Urine Renal Biomarkers to Cardiovascular Risk in Patients with Type 2 Diabetes Mellitus and Recent Acute Coronary Syndromes (From the EXAMINE Trial)","volume":"123","author":"Vaduganathan","year":"2019","journal-title":"Am. J. Cardiol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1046\/j.1523-1755.2002.00433.x","article-title":"Kidney Injury Molecule-1 (KIM-1): A novel biomarker for human renal proximal tubule injury","volume":"62","author":"Han","year":"2002","journal-title":"Kidney Int."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Schmidt, I.M., Srivastava, A., Sabbisetti, V., McMahon, G.M., He, J., Chen, J., Kusek, J., Taliercio, J., Ricardo, A.C., and Hsu, C.Y. (2021). Chronic Kidney Disease Biomarkers Consortium and the CRIC Study Investigators. Plasma Kidney Injury Molecule 1 in CKD: Findings from the Boston Kidney Biopsy Cohort and CRIC Studies. Am. J. Kidney Dis., epub ahead of print.","DOI":"10.1053\/j.ajkd.2021.05.013"},{"key":"ref_22","first-page":"992","article-title":"Evaluation of kidney injury molecule-1 as a disease progression biomarker in diabetic nephropathy","volume":"35","author":"Khan","year":"2019","journal-title":"Pak. J. Med. Sci."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Kapoula, G.V., Kontou, P.I., and Bagos, P.G. (2020). Diagnostic Performance of Biomarkers Urinary KIM-1 and YKL-40 for Early Diabetic Nephropathy, in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis. Diagnostics, 10.","DOI":"10.3390\/diagnostics10110909"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Abdelraheem, S., Ahmed, N., Zahran, F.E., Mohammed, G., and Ibrahim, E.S.I. (2021). Diagnostic performance of kidney injury molecule-1 for detection of abnormal urinary albumin-to-creatinine ratio in type 2 diabetes mellitus. J. Immunoass. Immunochem., 1954947.","DOI":"10.1080\/15321819.2021.1954947"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1007\/s11255-019-02201-6","article-title":"Association of urinary monocyte chemoattractant protein-1 (MCP-1) and kidney injury molecule-1 (KIM-1) with risk factors of diabetic kidney disease in type 2 diabetes patients","volume":"51","author":"Siddiqui","year":"2019","journal-title":"Int. Urol. Nephrol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/jdi.13139","article-title":"Circulating kidney injury molecule-1 as a biomarker of renal parameters in diabetic kidney disease","volume":"11","author":"Gohda","year":"2020","journal-title":"J. Diabetes Investig."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1111\/dme.14280","article-title":"Panel of novel urine biomarkers for incident microalbuminuria in people with type 2 diabetes mellitus","volume":"37","author":"Yamashita","year":"2020","journal-title":"Diabet. Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1007\/s00125-019-4915-0","article-title":"Biomarker panels associated with progression of renal disease in type 1 diabetes","volume":"62","author":"Colombo","year":"2019","journal-title":"Diabetologia"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1007\/s00125-019-05081-8","article-title":"Comparison of serum and urinary biomarker panels with albumin\/creatinine ratio in the prediction of renal function decline in type 1 diabetes","volume":"63","author":"Colombo","year":"2020","journal-title":"Diabetologia"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2786","DOI":"10.1681\/ASN.2016101101","article-title":"Plasma Biomarkers and Kidney Function Decline in Early and Established Diabetic Kidney Disease","volume":"28","author":"Coca","year":"2017","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1080\/03009734.2019.1696430","article-title":"Growth differentiation factor 15 (GDF-15) is a potential biomarker of both diabetic kidney disease and future cardiovascular events in cohorts of individuals with type 2 diabetes: A proteomics approach","volume":"125","author":"Carlsson","year":"2020","journal-title":"Upsala J. Med. Sci."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.plipres.2010.10.005","article-title":"Functional and pathological roles of the 12-and 15-lipoxygenases","volume":"50","author":"Dobrian","year":"2011","journal-title":"Prog. Lipid Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1210\/en.2006-0665","article-title":"The role of 12\/15-lipoxygenase in the expression of interleukin-6 and tumor necrosis factor-alpha in macrophages","volume":"148","author":"Wen","year":"2007","journal-title":"Endocrinology"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jsbmb.2018.10.022","article-title":"5-Lipoxygenase (ALOX5): Genetic susceptibility to type 2 diabetes and vitamin D effects on monocytes","volume":"187","author":"Nejatian","year":"2019","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"E1713","DOI":"10.1210\/jc.2013-4461","article-title":"Adipose tissue 12\/15 lipoxygenase pathway in human obesity and diabetes","volume":"99","author":"Lieb","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1159\/000496440","article-title":"Roles of 12-Lipoxygenase and Its Interaction with Angiotensin II on p21 and p27 Expression in Diabetic Nephropathy","volume":"142","author":"Zhang","year":"2019","journal-title":"Nephron"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"173122","DOI":"10.1016\/j.ejphar.2020.173122","article-title":"12-Lipoxygenase as a key pharmacological target in the pathogenesis of diabetic nephropathy","volume":"879","author":"Dong","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Xu, H.Z., Cheng, Y.L., Wang, W.N., Wu, H., Zhang, Y.Y., Zang, C.S., and Xu, Z.G. (2016). 12-Lipoxygenase Inhibition on Microalbuminuria in Type-1 and Type-2 Diabetes Is Associated with Changes of Glomerular Angiotensin II Type 1 Receptor Related to Insulin Resistance. Int. J. Mol. Sci., 17.","DOI":"10.3390\/ijms17050684"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1111\/1440-1681.13471","article-title":"Increased lipoxygenase and decreased cytochrome P450s metabolites correlated with the incidence of diabetic nephropathy: Potential role of eicosanoids from metabolomics in type 2 diabetic patients","volume":"48","author":"Peng","year":"2021","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"ref_40","first-page":"1940","article-title":"A 12-lipoxygenase product, 12-hydroxyeicosatetraenoic acid, is increased in diabetics with incipient and early renal disease","volume":"81","author":"Antonipillai","year":"1996","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"144551","DOI":"10.1016\/j.gene.2020.144551","article-title":"The ALOXA5AP gene (rs38022789) is associated with diabetic nephropathy in Slovenian patients with type 2 diabetes mellitus","volume":"741","author":"Makuc","year":"2020","journal-title":"Gene"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1053\/j.ajkd.2007.12.033","article-title":"Association of arachidonate 12-lipoxygenase genotype variation and glycemic control with albuminuria in type 2 diabetes","volume":"52","author":"Liu","year":"2008","journal-title":"Am. J. Kidney Dis."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s11255-017-1755-z","article-title":"Association of ALOX12 gene polymorphism with all-cause and cardiovascular mortality in diabetic nephropathy","volume":"50","author":"Roumeliotis","year":"2018","journal-title":"Int. Urol. Nephrol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"170153","DOI":"10.1155\/2010\/170153","article-title":"Human lipoxygenase pathway gene variation and association with markers of subclinical atherosclerosis in the diabetes heart study","volume":"2010","author":"Burdon","year":"2010","journal-title":"Mediat. Inflamm."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1159\/000488124","article-title":"Vasopressin and Diabetic Kidney Disease","volume":"72","year":"2018","journal-title":"Ann. Nutr. Metab."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1373\/clinchem.2005.060038","article-title":"Assay for the measurement of copeptin, a stable peptide derived from the precursor of vasopressin","volume":"52","author":"Morgenthaler","year":"2006","journal-title":"Clin. Chem."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"503","DOI":"10.2337\/diab.28.5.503","article-title":"Plasma vasopressin in uncontrolled diabetes mellitus","volume":"28","author":"Zerbe","year":"1979","journal-title":"Diabetes"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1016\/j.jdiacomp.2016.07.017","article-title":"Serum levels of copeptin are associated with type 2 diabetes and diabetic complications in Chinese population","volume":"30","author":"Zhu","year":"2016","journal-title":"J. Diabetes Complicat."},{"key":"ref_49","first-page":"E317","article-title":"Regulation of plasma vasopressin in insulin-dependent diabetes mellitus","volume":"249","author":"Zerbe","year":"1985","journal-title":"Am. J. Physiol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"10397","DOI":"10.1073\/pnas.96.18.10397","article-title":"Vasopressin contributes to hyperfiltration, albuminuria, and renal hypertrophy in diabetes mellitus: Study in vasopressin-deficient Brattleboro rats","volume":"96","author":"Bardoux","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1093\/ndt\/gfg277","article-title":"Diabetes-induced albuminuria: Role of antidiuretic hormone as revealed by chronic V2 receptor antagonism in rats","volume":"18","author":"Bardoux","year":"2003","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/j.jdiacomp.2017.04.005","article-title":"Antagonism of vasopressin V2 receptor improves albuminuria at the early stage of diabetic nephropathy in a mouse model of type 2 diabetes","volume":"31","author":"Taveau","year":"2017","journal-title":"J. Diabetes Complicat."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"107807","DOI":"10.1016\/j.jdiacomp.2020.107807","article-title":"Vasopressin associated with renal vascular resistance in adults with longstanding type 1 diabetes with and without diabetic kidney disease","volume":"35","author":"Piani","year":"2021","journal-title":"J. Diabetes Complicat."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1007\/s00125-013-2922-0","article-title":"Copeptin, a surrogate marker for arginine vasopressin, is associated with declining glomerular filtration in patients with diabetes mellitus (ZODIAC-33)","volume":"56","author":"Boertien","year":"2013","journal-title":"Diabetologia"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.jdiacomp.2016.11.015","article-title":"Albuminuria is associated with greater copeptin concentrations in men with type 1 diabetes: A brief report from the T1D exchange Biobank","volume":"31","author":"Bjornstad","year":"2017","journal-title":"J. Diabetes Complicat."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.arcmed.2020.05.018","article-title":"Relation of Copeptin with Diabetic and Renal Function Markers Among Patients with Diabetes Mellitus Progressing Towards Diabetic Nephropathy","volume":"51","author":"Noor","year":"2020","journal-title":"Arch. Med. Res."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.jdiacomp.2016.04.012","article-title":"Elevated copeptin is associated with atherosclerosis and diabetic kidney disease in adults with type 1 diabetes","volume":"30","author":"Bjornstad","year":"2017","journal-title":"J. Diabetes Complicat."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"3639","DOI":"10.2337\/dc13-0683","article-title":"Plasma copeptin and renal outcomes in patients with type 2 diabetes and albuminuria","volume":"36","author":"Velho","year":"2013","journal-title":"Diabetes Care"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/j.jdiacomp.2015.07.006","article-title":"Association between copeptin and declining glomerular filtration rate in people with newly diagnosed diabetes. The Skaraborg Diabetes Register","volume":"29","author":"Pikkemaat","year":"2015","journal-title":"J. Diabetes Complicat."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1111\/pedi.12909","article-title":"Elevated copeptin, arterial stiffness, and elevated albumin excretion in adolescents with type 1 diabetes","volume":"20","author":"Wiromrat","year":"2019","journal-title":"Pediatr. Diabetes"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s12933-018-0753-5","article-title":"Plasma copeptin, kidney disease, and risk for cardiovascular morbidity and mortality in two cohorts of type 2 diabetes","volume":"17","author":"Velho","year":"2018","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"3201","DOI":"10.2337\/dc12-2165","article-title":"Copeptin, a surrogate marker for arginine vasopressin, is associated with cardiovascular and all-cause mortality in patients with type 2 diabetes (ZODIAC-31)","volume":"36","author":"Riphagen","year":"2013","journal-title":"Diabetes Care"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.2337\/dc08-2168","article-title":"Endothelial markers may link kidney function to cardiovascular events in type 2 diabetes","volume":"32","author":"Maier","year":"2009","journal-title":"Diabetes Care"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.2337\/dc16-1003","article-title":"Plasma Copeptin, Kidney Outcomes, Ischemic Heart Disease, and All-Cause Mortality in People with Long-standing Type 1 Diabetes","volume":"39","author":"Velho","year":"2016","journal-title":"Diabetes Care"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/bs.pmbts.2017.02.005","article-title":"Biochemical and Biological Attributes of Matrix Metalloproteinases","volume":"147","author":"Cui","year":"2017","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/s41581-021-00415-5","article-title":"Key metalloproteinase-mediated pathways in the kidney","volume":"17","author":"Wozniak","year":"2021","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"e6067","DOI":"10.7717\/peerj.6067","article-title":"Association of urinary activity of MMP-9 with renal impairment in Mexican patients with type 2 diabetes mellitus","volume":"6","author":"Sampieri","year":"2018","journal-title":"PeerJ"},{"key":"ref_68","first-page":"31","article-title":"Comparison Between Biomarkers of Kidney Injury, Inflammation, and Oxidative Stress in Patients with Diabetic Nephropathy and Type 2 Diabetes Mellitus","volume":"14","author":"Aghadavod","year":"2020","journal-title":"Iran. J. Kidney Dis."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/s41598-019-56856-3","article-title":"MMP-10 is Increased in Early Stage Diabetic Kidney Disease and can be Reduced by Renin-Angiotensin System Blockade","volume":"10","author":"Orbe","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.clinbiochem.2010.02.006","article-title":"Urinary matrix metalloproteinase-8 and -9 activities in type 2 diabetic subjects: A marker of incipient diabetic nephropathy?","volume":"43","author":"Hanemaaijer","year":"2010","journal-title":"Clin. Biochem."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12933-015-0195-2","article-title":"EURODIAB Prospective Complications Study Group. Plasma levels of matrix metalloproteinase-2, -3, -10, and tissue inhibitor of metalloproteinase-1 are associated with vascular complications in patients with type 1 diabetes: The EURODIAB Prospective Complications Study","volume":"14","author":"Peeters","year":"2015","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.2337\/dc20-0630","article-title":"Profibrotic Circulating Proteins and Risk of Early Progressive Renal Decline in Patients with Type 2 Diabetes With and Without Albuminuria","volume":"43","author":"Ihara","year":"2020","journal-title":"Diabetes Care"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.diabres.2010.01.004","article-title":"Serum MMP-7 is increased in diabetic renal disease and diabetic diastolic dysfunction","volume":"87","author":"Ban","year":"2010","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/s12933-017-0620-9","article-title":"Circulating matrix metalloproteinases are associated with arterial stiffness in patients with type 1 diabetes: Pooled analysis of three cohort studies","volume":"16","author":"Peeters","year":"2017","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1161\/ATVBAHA.115.305631","article-title":"SUMMIT Consortium. Elevated Plasma Levels of MMP-12 Are Associated with Atherosclerotic Burden and Symptomatic Cardiovascular Disease in Subjects With Type 2 Diabetes","volume":"35","author":"Goncalves","year":"2015","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.jdiacomp.2015.05.004","article-title":"Matrix metalloproteinase-2 (MMP-2) gene polymorphism and cardiovascular comorbidity in type 2 diabetes patients","volume":"29","author":"Buraczynska","year":"2015","journal-title":"J. Diabetes Complicat."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1359\/JBMR.0301264","article-title":"FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis","volume":"19","author":"Shimada","year":"2004","journal-title":"J. Bone Miner. Res."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"e12987","DOI":"10.1111\/eci.12987","article-title":"Correlations between plasma strontium concentration, components of calcium and phosphate metabolism and renal function in type 2 diabetes mellitus","volume":"48","author":"Gant","year":"2018","journal-title":"Eur. J. Clin. Investig."},{"key":"ref_79","first-page":"93","article-title":"Circulating Fibroblast Growth Factors 21 and 23 as Biomarkers of Progression in Diabetic Nephropathy in Type 2 Diabetes with Normoalbuminuria","volume":"24","year":"2017","journal-title":"Egypt. J. Immunol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jdiacomp.2015.11.006","article-title":"Altered serum levels of FGF-23 and magnesium are independent risk factors for an increased albumin-to-creatinine ratio in type 2 diabetics with chronic kidney disease","volume":"30","author":"Silva","year":"2016","journal-title":"J. Diabetes Complicat."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2215\/CJN.04250510","article-title":"FGF-23 as a predictor of renal outcome in diabetic nephropathy","volume":"6","author":"Titan","year":"2011","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s11255-015-1190-y","article-title":"Fibroblast growth factor-23 but not sKlotho levels are related to diastolic dysfunction in type 1 diabetic patients with early diabetic nephropathy","volume":"48","author":"Dogan","year":"2016","journal-title":"Int. Urol. Nephrol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/s12933-020-01135-z","article-title":"Fibroblast growth factor-23 is associated with imaging markers of diabetic cardiomyopathy and anti-diabetic therapeutics","volume":"19","author":"Bojer","year":"2020","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1159\/000443241","article-title":"Plasma FGF23 and Calcified Atherosclerotic Plaque in African Americans with Type 2 Diabetes Mellitus","volume":"42","author":"Freedman","year":"2015","journal-title":"Am. J. Nephrol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1007\/s00125-018-4641-z","article-title":"Multiplex proteomics for prediction of major cardiovascular events in type 2 diabetes","volume":"61","author":"Nowak","year":"2018","journal-title":"Diabetologia"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.2337\/dc19-0528","article-title":"Fibroblast Growth Factor 23 and Mortality in Patients with Type 2 Diabetes and Normal or Mildly Impaired Kidney Function","volume":"42","author":"Yeung","year":"2019","journal-title":"Diabetes Care"},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Lee, J.E., Gohda, T., Walker, W.H., Skupien, J., Smiles, A.M., Holak, R.R., Jeong, J., McDonnell, K.P., Krolewski, A.S., and Niewczas, M.A. (2013). Risk of ESRD and all cause mortality in type 2 diabetes according to circulating levels of FGF-23 and TNFR1. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0058007"},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Silva, A.P., Mendes, F., Carias, E., Gon\u00e7alves, R.B., Fragoso, A., Dias, C., Tavares, N., Caf\u00e9, H.M., Santos, N., and Rato, F. (2019). Plasmatic Klotho and FGF23 Levels as Biomarkers of CKD-Associated Cardiac Disease in Type 2 Diabetic Patients. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20071536"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41581-018-0078-3","article-title":"The Klotho proteins in health and disease","volume":"15","author":"Kuro","year":"2019","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.jdiacomp.2016.11.008","article-title":"Serum klotho protein levels and their correlations with the progression of type 2 diabetes mellitus","volume":"31","author":"Nie","year":"2017","journal-title":"J. Diabetes. Complicat."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.jdiacomp.2018.06.002","article-title":"Clinical implication of alterations in serum Klotho levels in patients with type 2 diabetes mellitus and its associated complications","volume":"32","author":"Zhang","year":"2018","journal-title":"J. Diabetes Complicat."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1136\/jim-2016-000142","article-title":"Soluble Klotho and fibroblast growth factor 23 levels in diabetic nephropathy with different stages of albuminuria","volume":"64","author":"Inci","year":"2016","journal-title":"J. Investig. Med."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.diabres.2014.08.026","article-title":"The changes of serum sKlotho and NGAL levels and their correlation in type 2 diabetes mellitus patients with different stages of urinary albumin","volume":"106","author":"Wu","year":"2014","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1007\/s11255-017-1646-3","article-title":"Klotho levels: Association with insulin resistance and albumin-to-creatinine ratio in type 2 diabetic patients","volume":"49","author":"Silva","year":"2017","journal-title":"Int. Urol. Nephrol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.nefro.2018.08.004","article-title":"Rapid decline of kidney function in diabetic kidney disease is associated with high soluble Klotho levels","volume":"39","author":"Bob","year":"2019","journal-title":"Nefrologia"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1210\/jc.2018-00004","article-title":"Reduced Levels of Anti-Ageing Hormone Klotho Predict Renal Function Decline in Type 2 Diabetes","volume":"103","author":"Fountoulakis","year":"2018","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.kint.2015.11.007","article-title":"Megalin and cubilin in proximal tubule protein reabsorption: From experimental models to human disease","volume":"89","author":"Nielsen","year":"2016","journal-title":"Kidney Int."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.2337\/dc09-0112","article-title":"Microalbuminuria in type 1 diabetes is associated with enhanced excretion of the endocytic multiligand receptors megalin and cubilin","volume":"32","author":"Thrailkill","year":"2009","journal-title":"Diabetes Care"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"803","DOI":"10.2337\/db15-1313","article-title":"Genome-wide Association Studies Identify Genetic Loci Associated with Albuminuria in Diabetes","volume":"65","author":"Teumer","year":"2016","journal-title":"Diabetes"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1159\/000494391","article-title":"Cubilin Single Nucleotide Polymorphism Variants are Associated with Macroangiopathy While a Matrix Metalloproteinase-9 Single Nucleotide Polymorphism Flip-Flop may Indicate Susceptibility of Diabetic Nephropathy in Type-2 Diabetic Patients","volume":"141","author":"Albert","year":"2019","journal-title":"Nephron"},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"Ding, Y., Sun, X., and Shan, P.F. (2017). MicroRNAs and Cardiovascular Disease in Diabetes Mellitus. Biomed. Res. Int., 2017.","DOI":"10.1155\/2017\/4080364"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1080\/1354750X.2016.1204004","article-title":"Circulating endothelium-enriched microRNA-126 as a potential biomarker for coronary artery disease in type 2 diabetes mellitus patients","volume":"22","author":"Sabry","year":"2017","journal-title":"Biomarkers"},{"key":"ref_103","doi-asserted-by":"crossref","unstructured":"Ismail, N., Abdullah, N., Abdul Murad, N.A., Jamal, R., and Sulaiman, S.A. (2021). Long Non-Coding RNAs (lncRNAs) in Cardiovascular Disease Complication of Type 2 Diabetes. Diagnostics, 11.","DOI":"10.3390\/diagnostics11010145"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"3027","DOI":"10.2337\/db07-0675","article-title":"Variants in the plasmacytoma variant translocation gene (PVT1) are associated with end-stage renal disease attributed to type 1 diabetes","volume":"56","author":"Millis","year":"2007","journal-title":"Diabetes"},{"key":"ref_105","doi-asserted-by":"crossref","unstructured":"Luo, F., Wang, T., Zeng, L., Zhu, S., Cao, W., Wu, W., Wu, H., and Zou, T. (2018). Diagnostic potential of circulating LncRNAs in human cardiovascular disease: A meta-analysis. Biosci. Rep., 38.","DOI":"10.1042\/BSR20181610"},{"key":"ref_106","doi-asserted-by":"crossref","unstructured":"Zaiou, M. (2020). circRNAs Signature as Potential Diagnostic and Prognostic Biomarker for Diabetes Mellitus and Related Cardiovascular Complications. Cells, 9.","DOI":"10.3390\/cells9030659"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"4520","DOI":"10.1002\/jcp.29329","article-title":"Circ_0080425 inhibits cell proliferation and fibrosis in diabetic nephropathy via sponging miR-24-3p and targeting fibroblast growth factor 11","volume":"235","author":"Liu","year":"2020","journal-title":"J. Cell. Physiol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"22384","DOI":"10.1038\/srep22384","article-title":"Reciprocal Changes of Circulating Long Non-Coding RNAs ZFAS1 and CDR1AS Predict Acute Myocardial Infarction","volume":"6","author":"Zhang","year":"2016","journal-title":"Sci. Rep."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/20\/11196\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:16:44Z","timestamp":1760167004000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/20\/11196"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,17]]},"references-count":108,"journal-issue":{"issue":"20","published-online":{"date-parts":[[2021,10]]}},"alternative-id":["ijms222011196"],"URL":"https:\/\/doi.org\/10.3390\/ijms222011196","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,17]]}}}